Project Heka offers selected parties the opportunity to explore the investment in the fundraising of a life sciences company.
•With seven verticals in play, the market opportunity is significant. A collective Serviceable Obtainable Market figure of £375m for the current and planned core products and accessories over the next 5 years are targeted, against a Serviceable Addressable Market value of £112bn.
•Currently trading with a track record in the UK, USA, Europe and Middle East. •The opportunity to enter new markets, target wider audiences and introduce new products could be introduced.
•An exit strategy could be targeted by 2024/25, either through a strategic trade sale or an IPO.
•Looking for an investment of £12m in Series A from a single or multiple investors to accelerate growth by scaling sales activities, facilitating international and product range expansion.